Jaundice, Obstructive clinical trials

The registry lists 62 studies for Jaundice, Obstructive across more than 10 countries. 15 are recruiting or about to start. 38 of them are mainly about Jaundice, Obstructive (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.

Get an email when these change. Save the Jaundice, Obstructive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Status unknown: 14
Recruiting: 8
Not yet recruiting: 7
Withdrawn: 2
Active, not recruiting: 1

Phase

Phase 2: 8
Phase 3: 3
Phase 4: 2
Phase 1: 2

Where

China: 14
Egypt: 9
United States: 7
France: 4
India: 3
Korea, Republic of: 3

Who runs them

Sohag University (6) · Zhejiang University (3) · POLYSAN Scientific & Technological Pharmaceutical Company (3) · Peking Union Medical College Hospital (2) · Weill Medical College of Cornell University (2) · AdventHealth (2) · Asian Institute of Gastroenterology, India (2) · Samsung Medical Center (2)

What is being tested here

Drugs under test in Jaundice, Obstructive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Ringer's Solution	2	2
Dihematoporphyrin Ether	0	1
SMOFlipid	0	1
Methylene Blue	0	1
Ursodeoxycholic Acid	0	1

Coming up

0phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Nov 2026Determinants of Technical Success and Safety in Therapeutic ERCP for Obstructive Jaundice · Sohag University
Dec 2026Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study · Zhejiang University
Dec 2026A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice · Ruijin Hospital
Jun 2027Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation · Zhejiang University

Who these studies take

Of the 8 Jaundice, Obstructive studies recruiting now, 6 (75%) set no upper age limit and 1 (13%) stop at 75 or younger. 1 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (25%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	1 (13%)	1 (13%)
18	8 (100%)	8 (100%)
30	8 (100%)	8 (100%)
40	8 (100%)	8 (100%)
50	8 (100%)	8 (100%)
65	8 (100%)	8 (100%)
75	8 (100%)	8 (100%)
85	7 (88%)	7 (88%)

Across all 62 studies, recruiting or not: 19% stop at 75 or younger and 3% at 65; 10% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 → or search them.